Skip to content
General News, Mental Health

Optimism may be increased by taking psychedelic compound psilocybin: study

Monash University 2 mins read

Monash University researchers have made a breakthrough in the study of psychedelics to treat disorders including major depression, demonstrating that rats given psilocybin exhibit increased optimism over time.

Psilocybin is a psychedelic compound found in magic mushrooms that has shown promise as a novel treatment for depression. However, the information processing mechanisms affected by psilocybin are not well understood.


Now, a cross-disciplinary team at Monash University has used computational modelling to demonstrate that rats given psilocybin display long-lasting, increased optimistic behaviour to perform reward-based tasks.


The findings, published in 
Translational Psychiatry, suggest psilocybin may be helpful for addressing the core symptoms of major depression and other conditions characterised by reduced engagement and withdrawal.


Monash PhD candidate
Elizabeth (Beth) Fisher led the study, working with Professor Jakob Hohwy from the Monash Centre for Consciousness and Contemplative Studies (M3CS) and Dr Claire Foldi from the Monash Biomedicine Discovery Institute.


Professor Hohwy says the results are a promising step toward explaining the mechanisms of how psychedelics may work to change the brain and increase engagement after treatment:


“Our team found that rats given psilocybin were more motivated to explore their environment and perform reward-based tasks. These exciting results show the mechanisms of how psilocybin may work to increase optimism in an animal model, which we hope may translate to humans as well.”


Beth Fisher said that the study should motivate confirmation of these effects in human studies:


“Insights into the mechanisms of psilocybin allow us to unpack who may benefit from psychedelic therapies as well as who these treatments may not be beneficial for.


“With many people around the world affected by depression, our ultimate goal is to help build understanding of how psilocybin might be used to treat core symptoms people experience, such as diminished optimism, apathy and withdrawal from the world around them.”


To view the research paper, please visit: 
Psilocybin increases optimistic engagement over time: computational modelling of behaviour in rats | Translational Psychiatry (nature.com)

 


Contact details:


Michelle Robertson
[email protected]
0458 281 704

GENERAL MEDIA ENQUIRIES

Monash Media
T: +61 (0) 3 9903 4840
E: [email protected]

For more Monash media stories, visit our news and events site

More from this category

  • Community, General News
  • 16/01/2026
  • 08:20
Australia Day Council SA

AUSTRALIA DAY AUS LIGHTS PARADE ROUTE ANNOUNCED TODAY AND YOU’RE INVITED!

INTERVIEWS ARE NOW AVAILABLE WITH ALL SPOKESPEOPLE ON THEFACTSHEET 16 January 2026: The Australia Day Council of South Australia has today announced the official…

  • Contains:
  • Mental Health, Research Development
  • 16/01/2026
  • 06:00
University of Sydney Brain and Mind Centre

New study reveals clues as to why standard antidepressants fail for so many Aussies

A groundbreaking study from the University of Sydney’s Brain and Mind Centre reveals new clues as to why standard antidepressants fail for many Australians, opening the door for more effective, personalised treatments. Examining nearly 15,000 Australians with depression in one of the largest studies of its kind, researchers from the Brain and Mind Centre’s Youth Mental Health and Technology team identified a clinically distinct “atypical depression” subtype that is strongly linked to other mental and physical illnesses like diabetes. Published in the journal Biological Psychiatry, the study found that this atypical depression group (21 per cent of the study sample)…

  • General News
  • 15/01/2026
  • 19:26
GeekyAnts

GeekyAnts Announces Expo Feature Featuring Co-Founder Sanket Sahu on In-Browser Development Infrastructure

SAN FRANCISCO, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Sanket Sahu, the co-founder of GeekyAnts and creator of gluestack, recently shared his insights and has been featured in a technical publication by Expo.The featured publication, 'How I built a dev server entirely in the browser,' offers an in-depth analysis of the pioneering browser-native architecture engineered by GeekyAnts to drive the future of development environments.By focusing on complex organizational needs and product innovation, GeekyAnts remains at the forefront of legacy system modernization. The feature effectively highlights how our browser-based infrastructure developments continue to define the standard for the React Native ecosystem.The full technical…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.